Our Only Competition Is OurselvesIn rereading the June 26th PR about the 'new and improved TLC 3200' , it states that until the new version gets the ITA and REB from each site the enrolled patients can be treated with the currently approved version. Here's where the competition from Ourselves comes. The PR then goes on to state 6 great advantages of waiting for the NEW TLC 3200 to come out. What it doesn't state is that the ITA and REB news approvals may take awhile. Here's where the summer vacation delays come in. It's not the doctors who will treat the patients it's the administrators who don't have a vested interest in a quick approval. Our potential patients for our ph2 trial are facing stiff competition from that Theralase company that offers this greatly improved equipment and procedure BUT at a future date. Meanwhile, NO PR yet that any patients have been treated with the current TLC3200.